Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ligand Pharm (LGND)

Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Ligand: Q4 Earnings Snapshot

Ligand: Q4 Earnings Snapshot

LGND : 73.10 (+2.57%)
Ligand: Q3 Earnings Snapshot

Ligand: Q3 Earnings Snapshot

LGND : 73.10 (+2.57%)
Ligand: Q2 Earnings Snapshot

Ligand: Q2 Earnings Snapshot

LGND : 73.10 (+2.57%)
Exelixis (EXEL) Q1 Earnings Miss, Revenues Increase Y/Y

Exelixis (EXEL) misses first quarter 2023 earnings and sales estimates, but product sales increase year over year.

BMY : 54.23 (+1.84%)
EXEL : 23.73 (-0.54%)
LGND : 73.10 (+2.57%)
SPRO : 1.7200 (-1.71%)
bluebird (BLUE) Posts Q1 Earnings, Focuses on Zynteglo, Skysona

bluebird bio (BLUE) delivers earnings of 21 cents per share in the first quarter, due to a one-time gain. Revenues increase year over year.

LGND : 73.10 (+2.57%)
PCRX : 29.22 (+0.62%)
BLUE : 1.2800 (-6.23%)
SPRO : 1.7200 (-1.71%)
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View

Novavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However, shares rise on the back of encouraging 2023 guidance and cost-reduction initiatives.

NVAX : 4.78 (-1.44%)
LGND : 73.10 (+2.57%)
ALLO : 4.47 (+0.22%)
ATHA : 2.74 (+7.03%)
Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus

Denali (DNLI) delivers a wider Q1 loss while collaboration revenues surpass estimates.

SNY : 48.60 (-1.90%)
BIIB : 215.63 (-0.33%)
LGND : 73.10 (+2.57%)
DNLI : 20.52 (-1.20%)
Viatris (VTRS) Q1 Earnings Beat, Revenues Miss Estimates

Viatris (VTRS) beats on Q1 earnings but misses sales. The company is now looking to reshape its business after selling its biosimilars portfolio.

LGND : 73.10 (+2.57%)
PCRX : 29.22 (+0.62%)
SPRO : 1.7200 (-1.71%)
VTRS : 11.94 (+0.93%)
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings

Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.

LGND : 73.10 (+2.57%)
VKTX : 82.00 (-1.61%)
TVTX : 7.71 (+0.52%)
OABI : 5.42 (+0.56%)
Wall Street Analysts Believe Ligand (LGND) Could Rally 38.66%: Here's is How to Trade

The mean of analysts' price targets for Ligand (LGND) points to a 38.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...

LGND : 73.10 (+2.57%)

Barchart Exclusives

What The USDA Prospective Plantings Report Means For Grains
Taking a look at the USDA Prospective Plantings report, what was surprising and why it opens the door to speculators reevaluating risk. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar